SCHEMBL28967239

SCHEMBL28967239

COc1ccc(CCN2C(=O)CCCC2=O)cc1

nearest known ligand 0.64

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 2/20 0.64
GSK3B P49841 2/20 0.64
HRH3 Q9Y5N1 3/20 0.57
SIGMAR1 Q99720 1/20 0.56
ALDH1A1 P00352 4/20 0.55
MEN1 O00255 1/20 0.54
TSHR P16473 1/20 0.54
KMT2A Q03164 1/20 0.54
POLB P06746 2/20 0.51
GAA P10253 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA4 P22748 1/20 0.49
CA9 Q16790 1/20 0.49
CMA1 P23946 1/20 0.49
MAPT P10636 1/20 0.48
HTT P42858 1/20 0.48
DAO P14920 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL40778 0.83 CMA1 (0.66) GSK3AGSK3BALDH1A1MEN1KMT2A
SCHEMBL16429902 0.81 KMT2A (0.64) GSK3AGSK3BHRH3SIGMAR1ALDH1A1
SCHEMBL31175413 0.81 GSK3A (0.53) GSK3AGSK3BHRH3SIGMAR1ALDH1A1
SCHEMBL10195154 0.81 GSK3A (0.64) GSK3AGSK3BHRH3SIGMAR1ALDH1A1
SCHEMBL22944366 0.79 GSK3A (0.40) GSK3AGSK3BHRH3SIGMAR1ALDH1A1
SCHEMBL12615721 0.78 GSK3A (0.60) GSK3AGSK3BHRH3SIGMAR1ALDH1A1
SCHEMBL3381344 0.78 GSK3A (1.00) GSK3AGSK3BHRH3SIGMAR1ALDH1A1
SCHEMBL17525752 0.78 CA1 (0.40) GSK3AGSK3BHRH3ALDH1A1CA1
SCHEMBL9390734 0.78 KMT2A (0.62) GSK3AGSK3BSIGMAR1ALDH1A1MEN1
SCHEMBL11432099 0.77 SIGMAR1 (0.60) GSK3AGSK3BHRH3SIGMAR1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116867758-A IRAK degradation agents and uses thereof 凯麦拉医疗公司 2023-10-10 CN disclosed
CN-115776891-A STAT degradants and uses thereof 凯麦拉医疗公司 2023-03-10 CN disclosed